Catalyst Biosciences, Inc. (:CBIO) and Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Placed on Most Volatile List

Recent action on shares of Catalyst Biosciences, Inc. (:CBIO) lands the stock on today’s most volatile list. In the current trading session, the stock has seen a change of 2.07% recently hitting $3.95.

Share prices are capable of moving sharply higher or lower in a very short amount of time. Keeping an eye on the volatile stocks may help spot market abnormalities.

Investors are frequently on the search for the secret to creating that winning portfolio. Many individual investors would agree that information is highly important when picking stocks. Possessing the correct information about a public company is of the utmost importance. Knowing how to interpret the information is another skill investors may need to master before becoming fully immersed in the stock market. Taking the time to properly examine a company before purchasing shares may be the difference between healthy profits and disappointing losses. If a company looks good after the research is complete, patience may still be desirable. Often times, a good stock will continue to be good in the future. Dealing with market volatility is normal, but exploring all aspects of a company may be a good way to combat day to day volatility.

Analyst Views

Based on data provided from analysts polled by Thomson Reuters, Catalyst Biosciences, Inc. has a current consensus target price of 12.33. The current consensus analyst recommendation is sitting at 1.70 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.

Moving Averages and ATR

After a recent spot-check, Catalyst Biosciences, Inc. (:CBIO)’s ATR is 0.28. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.

Taking a closer look into the volatility on shares of Catalyst Biosciences, Inc. (:CBIO), we notice that the stock is 14.16% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of 2.98% from current stock levels.

Going out even further, the 200-Day Simple Moving Average is recorded -35.40% away from the current share price. Company shares were recently noted -18.56% off of the 50-day high and 27.01% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -81.46% separated from the 52 week high and 27.01% from the low.

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) are showing high volatlity in today’s session as the stock has moved 2.24%, clocking in at $4.10 after a recent bid.

Volatility is the dispersion of returns for a given stock. It is quantified by short-term traders as the average difference between a stock’s daily high and daily low, then divided by the stock price. In other words, volatility refers to the amount of risk about the size of changes in a stock’s value. 

Based on data provided from analysts polled by Thomson Reuters, Marinus Pharmaceuticals, Inc. has a current consensus target price of 5.00. The current consensus analyst recommendation is sitting at 2.00 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.

After a recent spot-check, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)’s ATR is 0.39. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.

Taking a closer look into the volatility on shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), we notice that the stock is 31.05% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of 71.51% from current stock levels.

Going out even further, the 200-Day Simple Moving Average is recorded 162.42% away from the current share price. Company shares were recently noted -24.63% off of the 50-day high and 222.83% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -24.63% separated from the 52 week high and 399.21% from the low.

Leave a Comment